Abstract:Objective·To develop a machine learning approach for early identification of metabolic syndromes associated with inflammatory metabolic state changes in breast cancer patients after neoadjuvant therapy,using common laboratory and transthoracic echocardiography indices.Methods·Female patients with primary invasive breast cancer diagnosed at the Department of Breast Surgery,Renji Hospital,Shanghai Jiao Tong University School of Medicine,between September 2020 and September 2022,were included.General patient information,laboratory test results,and transthoracic echocardiography data were collected.After feature extraction,five machine learning algorithms,including random forest(RF),gradient boosting(GB),support vector machine(SVM),K-nearest neighbor(KNN),and decision tree(DT),were applied to construct a prediction model for the changes of the patients' metabolic state after neoadjuvant therapy,and the prediction performances of the five models were compared.Results·A total of 232 cases with valid clinical data were included,comprising 135 cases before neoadjuvant therapy and 97 cases after completing 4 cycles of neoadjuvant therapy.Feature extraction identified five key features:white blood cell count,hemoglobin,high-density lipoprotein(HDL),interleukin-2 receptor,and interleukin-8.In the multi-feature analysis,the area under the receiver operating characferistic curve(AUC)was higher in the combination of white blood cell count,hemoglobin and HDL compared to the combination of interleukin-2 receptor and interleukin-8(RF:0.928 vs 0.772,GB:0.900 vs 0.792,SVM:0.941 vs 0.764,KNN:0.907 vs 0.762,DT:0.799 vs 0.714).The RF,SVM,and GB models showed higher AUC(0.928,0.941,0.900)and accuracy(0.914,0.897,0.776).The SVM model exhibited superior accuracy in the training data compared to the RF and GB models(P=0.394,0.122 and 0.097,respectively).Conclusion·The SVM model can be used to establish a prediction model for identifying breast cancer patients at high risk of developing inflammatory metabolic state-related metabolic syndrome after neoadjuvant therapy by incorporating five common clinical indicators,namely,white blood cell count,hemoglobin,high-density lipoprotein,interleukin-2 receptor,and interleukin-8.SVM modeling may be useful for clinicians to establish individualized screening protocols based on a patient's inflammatory metabolic state.

Machine Learning and Metabolomics: Diagnosis of Malignant Breast Cancer

Integrative Analysis of Plasma Metabolomics and Proteomics Reveals the Metabolic Landscape of Breast Cancer

Breast Cancer Detection Using Targeted Plasma Metabolomics

Identification of a Novel Biomarker Panel for Breast Cancer Screening

Machine learning-informed liquid-liquid phase separation for personalized breast cancer treatment assessment

Diagnosis of breast cancer using HPLC metabonomics fingerprints coupled with computational methods.

Combining metabolomics and machine learning to discover biomarkers for early-stage breast cancer diagnosis

Machine Learning-Based LIBS Spectrum Analysis of Human Blood Plasma Allows Ovarian Cancer Diagnosis.

Early lung cancer diagnostic biomarker discovery by machine learning methods

Integrated Models of Blood Protein and Metabolite Enhance the Diagnostic Accuracy for Non-Small Cell Lung Cancer

Enhancing Breast Cancer Outcomes with Machine Learning-Driven Glutamine Metabolic Reprogramming Signature

Metabolic Detection of Malignant Brain Gliomas Through Plasma Lipidomic Analysis and Support Vector Machine-Based Machine Learning

Metabolomic machine learning predictor for diagnosis and prognosis of gastric cancer

Machine learning facilitates the application of mass spectrometry-based metabolomics to clinical analysis: A review of early diagnosis of high mortality rate cancers

Evaluation of Machine Learning Prediction of Altered Inflammatory Metabolic State after Neoadjuvant Therapy for Breast Cancer

Machine learning applications in breast cancer survival and therapeutic outcome prediction based on multi-omic analysis

Diagnostics of Thyroid Cancer Using Machine Learning and Metabolomics

Identification of Gene Expression in Different Stages of Breast Cancer with Machine Learning

Supervised Machine Learning for Breast Cancer Risk Factors Analysis and Survival Prediction

Integrating Somatic Mutations for Breast Cancer Survival Prediction Using Machine Learning Methods

Breast Cancer Prediction Based on Multiple Machine Learning Algorithms